Sunshine Biopharma Inc (SBFM)
0.93
-0.28
(-23.14%)
USD |
NASDAQ |
Apr 24, 16:00
1.00
+0.07
(+7.53%)
After-Hours: 07:01
Sunshine Biopharma Total Assets (Quarterly): 27.35M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 27.35M |
September 30, 2023 | 27.65M |
June 30, 2023 | 28.41M |
March 31, 2023 | 26.99M |
December 31, 2022 | 29.24M |
September 30, 2022 | 40.86M |
June 30, 2022 | 41.99M |
March 31, 2022 | 13.41M |
December 31, 2021 | 2.203M |
September 30, 2021 | 2.502M |
June 30, 2021 | 1.817M |
March 31, 2021 | 1.858M |
December 31, 2020 | 1.046M |
September 30, 2020 | 0.5505M |
June 30, 2020 | 0.1385M |
March 31, 2020 | 0.0637M |
December 31, 2019 | 0.0981M |
September 30, 2019 | 0.1463M |
June 30, 2019 | 0.1094M |
March 31, 2019 | 1.247M |
December 31, 2018 | 1.147M |
September 30, 2018 | 1.104M |
June 30, 2018 | 1.170M |
March 31, 2018 | 1.002M |
December 31, 2017 | 0.2575M |
Date | Value |
---|---|
September 30, 2017 | 0.256M |
June 30, 2017 | 0.1643M |
March 31, 2017 | 0.0234M |
December 31, 2016 | 0.0644M |
September 30, 2016 | 0.5993M |
June 30, 2016 | 0.6654M |
March 31, 2016 | 0.8306M |
December 31, 2015 | 0.6733M |
September 30, 2015 | 0.1366M |
June 30, 2015 | 0.1707M |
March 31, 2015 | 0.1487M |
December 31, 2014 | 0.1434M |
September 30, 2014 | 0.1803M |
June 30, 2014 | 0.0441M |
March 31, 2014 | 0.0718M |
December 31, 2013 | 0.0312M |
September 30, 2013 | 0.0716M |
June 30, 2013 | 0.1608M |
March 31, 2013 | 0.259M |
December 31, 2012 | 0.1348M |
September 30, 2012 | 0.268M |
June 30, 2012 | 0.109M |
March 31, 2012 | 0.0842M |
December 31, 2011 | 0.1064M |
September 30, 2011 | 0.2242M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.0637M
Minimum
Mar 2020
41.99M
Maximum
Jun 2022
12.97M
Average
2.203M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
Lexaria Bioscience Corp | 6.352M |
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 7.832M |
Xenon Pharmaceuticals Inc | 964.80M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 6.140M |
Shareholders Equity (Quarterly) | 21.21M |
Current Ratio | 4.483 |